Hypertensive Cardiovascular Disease: Pathophysiology and Treatment: Pathophysiology and Treatment: Developments in Cardiovascular Medicine, cartea 16
Editat de A. Amery, R. Fagard, P. Lijnen, J. Staessenen Limba Engleză Paperback – 11 noi 2011
Din seria Developments in Cardiovascular Medicine
- 5% Preț: 1484.50 lei
- 5% Preț: 375.17 lei
- 5% Preț: 354.10 lei
- 5% Preț: 1365.22 lei
- 5% Preț: 362.28 lei
- 5% Preț: 1056.66 lei
- 5% Preț: 1383.84 lei
- 5% Preț: 362.63 lei
- 5% Preț: 354.53 lei
- 5% Preț: 365.97 lei
- 5% Preț: 2037.17 lei
- 5% Preț: 353.48 lei
- 5% Preț: 352.79 lei
- 5% Preț: 357.17 lei
- 5% Preț: 357.01 lei
- 5% Preț: 753.57 lei
- 5% Preț: 686.22 lei
- 5% Preț: 1056.66 lei
- 5% Preț: 361.39 lei
- 5% Preț: 359.45 lei
- 5% Preț: 696.56 lei
- 5% Preț: 1062.27 lei
- 5% Preț: 2036.81 lei
- 5% Preț: 689.01 lei
- 5% Preț: 358.05 lei
- 5% Preț: 695.02 lei
- 5% Preț: 635.16 lei
- 5% Preț: 361.23 lei
- 5% Preț: 1369.25 lei
- 5% Preț: 688.32 lei
- 5% Preț: 760.80 lei
- 5% Preț: 693.42 lei
- 5% Preț: 3064.43 lei
- 5% Preț: 1364.49 lei
- 5% Preț: 754.97 lei
- 5% Preț: 687.61 lei
- 5% Preț: 356.81 lei
- 5% Preț: 362.08 lei
- 5% Preț: 635.88 lei
- 5% Preț: 354.53 lei
Preț: 392.18 lei
Preț vechi: 412.82 lei
-5% Nou
Puncte Express: 588
Preț estimativ în valută:
75.06€ • 79.18$ • 62.55£
75.06€ • 79.18$ • 62.55£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400974784
ISBN-10: 9400974787
Pagini: 1008
Ilustrații: 982 p.
Dimensiuni: 155 x 235 x 53 mm
Greutate: 1.38 kg
Ediția:Softcover reprint of the original 1st ed. 1982
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9400974787
Pagini: 1008
Ilustrații: 982 p.
Dimensiuni: 155 x 235 x 53 mm
Greutate: 1.38 kg
Ediția:Softcover reprint of the original 1st ed. 1982
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Cardiovascular Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Blood Pressure Control in Normotensive Subjects.- 1. Role of the kidney in blood pressure regulation.- 2. Role of central mechanisms in the blood pressure regulation.- 3. Arterial baroreflexes in normotensive and hypertensive man.- 4. Role of catecholamines in blood pressure regulation.- 5. Role of the renin-angiotensin system and prostaglandins in blood pressure regulation and sodium homeostasis.- 6. Role of kallikrein in blood pressure regulation.- 7. The lability of blood pressure.- II. Experimental Hypertension.- 8. Pathophysiology of hypertension in genetically hypertensive rats — environmental modification and prevention.- 9. The pathophysiology of hypertension: contributions of experimental pathophysiology.- III. Pathogenesis of Primary Hypertension.- 10. Role of changes in Na+ transport in cell membranes in the pathogenesis of primary hypertension.- 11. Pathophysiology of primary hypertension: role of adrenoceptors in the transformation from an early high cardiac output into a later high arteriolar resistance phase.- 12. Genetics in human hypertension.- 13. Psychophysiologic evidence for the role of the nervous system in hypertension.- 14. Interaction between functional and structural elements in primary hypertension.- 15. Role of the kidney in the pathogenesis of primary hypertension.- 16. Role of sodium in the pathogenesis of idiopathic hypertension.- 17. Role of obesity in the pathogenesis of primary hypertension.- 18. Role of catecholamines in the pathogenesis of primary hypertension.- 19. Role of renin in the control of the circulation in hypertensive disease and in heart failure.- 20. Blood pressure in the first years of life.- 21. Childhood hypertension.- 22. Hypertension in elderly.- 23. Borderline blood pressure elevation.- 24. Hemodynamics ofprimary hypertension.- IV. Repercussions of High Blood Pressure.- 25. Hypertension and the brain.- 26. The ocular fundus and hypertension.- 27. Influence of hypertension on the heart.- 28. Influence of hypertension on the kidney.- 29. Influence of hypertension on mortality.- 30. Malignant hypertension.- 31. Definition and classification of hypertension.- V. Secondary Hypertension.- 32. Hypertension secondary to coarctation.- 33. Hypertension secondary to renal parenchymal disease.- 34. Hypertension secondary to renovascular disease.- 35. Hypertension secondary to adrenal cortical disease.- 36. Hypertension secondary to pheochromocytoma.- 37. Hypertension secondary to thyroid dysfunction.- 38. Parathyroid function and hypertension.- 39. Hypertension in pregnancy.- 40. Hypertension secondary to contraceptive agents.- VI. Examination of the Hypertensive Patient.- 41. Clinical examination of the hypertensive patient including blood pressure measurement.- 42. Laboratory examination of the hypertensive patient.- 43. Radiological examination of the hypertensive patient.- VII. Antihypertensive Therapy.- 44. Non-drug treatment of hypertension.- 45. Diuretics as antihypertensive agents.- 46. Beta-adrenoceptor blocking drugs as antihypertensive agents.- 47. Alpha-adrenoreceptor antagonists in hypertension.- 48. Vasodilators as antihypertensive agents.- 49. Methyldopa as an antihypertensive agent.- 50. Clonidine and imidazolines as antihypertensive agents.- 51. Blockers of the neuromuscular junction as antihypertensive agents.- 52. Ganglion blockers as antihypertensive agents.- 53. Inhibitors of the renin-angiotensin system as antihypertensive agents.- 54. General strategy of antihypertensive treatment.- 55. The benefits of antihypertensive therapy.- 56. Hypertensive emergencies.-57. Anesthesia and surgery in the hypertensive patient.- 58. Quality of life in hypertensive patients.- 59. Compliance to antihypertensive therapy.- Index of Authors.- Drug Index.